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Post-traumatic stress disorder (PTSD) is a psychiatric condition characterized by intrusive
and persistent memories of a psychologically traumatic event that leads to significant
functional and social impairment in affected individuals. The molecular bases underlying
persistent outcomes of a transient traumatic event have remained elusive for many years,
but recent studies in rodents have implicated epigenetic modifications of chromatin struc-
ture and DNA methylation as fundamental mechanisms for the induction and stabilization
of fear memory. In addition to mediating adaptations to traumatic events that ultimately
cause PTSD, epigenetic mechanisms are also involved in establishing individual differences
in PTSD risk and resilience by mediating long-lasting effects of genes and early environment
on adult function and behavior. In this review, we discuss the current evidence for epige-
netic regulation of PTSD in human studies and in animal models and comment on ways
in which these models can be expanded. In addition, we identify key outstanding ques-
tions in the study of epigenetic mechanisms of PTSD in the context of rapidly evolving
technologies that are constantly updating and adjusting our understanding of epigenetic
modifications and their functional roles. Finally, we discuss the potential application of
epigenetic approaches in identifying markers of risk and resilience that can be utilized
to promote early intervention and develop therapeutic strategies to combat PTSD after
symptom onset.
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Post-traumatic stress disorder (PTSD) is a devastating psychiatric
condition that develops in the aftermath of a traumatic life event.
It is characterized by persistent and intrusive memories that inter-
fere with daily functioning, often to the point of physical and
emotional disability (American Psychiatric Association, 2000). In
recent years, epigenetic mechanisms in the central nervous system
emerged as the long sought-after link between transient environ-
mental stimuli, including trauma, and persistent changes in gene
expression and behavior (Zovkic et al., 2013). Epigenetic mech-
anisms were initially implicated in behavior through their ability
to shape stress- and mood-associated neural and behavioral out-
comes caused by early life experiences (Champagne and Meaney,
2001; Meaney, 2001; Fish et al., 2004; Weaver et al., 2004a,b).
Shortly after, the epigenetic mechanisms once thought to be sta-
ble across the lifespan were found to be dynamically regulated
during learning and memory in adult rodents (Levenson and
Sweatt, 2005, 2006; Chwang et al., 2006; Levenson et al., 2006;
Lubin and Sweatt, 2007; Miller and Sweatt, 2007). This temporal
duality implicated epigenetic mechanisms in shaping individual
variation in risk and resilience in response to early life experiences
and in mediating environmental triggers of psychiatric disorders
in adulthood (McGowan et al., 2009; Labonte et al., 2012; Russo
et al., 2012; Zovkic and Sweatt, 2013).
Vast individual differences in PTSD prevalence among people
exposed to traumatic events (Kessler et al., 1995), the contribu-
tion of early life events to adult risk for psychopathology (Yehuda
and Bierer, 2009; Kremen et al., 2012; Russo et al., 2012), and
the ability of stressors to regulate gene expression (Cullinan et al.,
1995) pointed to epigenetic involvement in PTSD before any direct
evidence for a link was available (e.g., Yehuda and Bierer, 2009).
Soon, human studies provided evidence linking epigenetics with
PTSD, either as a consequence of trauma or as a mediator of gene-
environment interactions in PTSD risk and resilience (e.g., Ressler
et al., 2011; Skelton et al., 2012; Klengel et al., 2013; Norrholm et al.,
2013). While comparatively few animal studies have directly inves-
tigated epigenetic involvement in PTSD, the related literature on
the epigenetics of stress and fear conditioning provides important
insights into the role of these mechanisms in establishing persis-
tent fear in response to stressful stimuli (Zovkic and Sweatt, 2013).
Thus, one of our goals is to review the relatively small literature that
directly addresses the involvement of epigenetics in PTSD and put
it into the broader context of epigenetics in stress and fear learning.
Given that approximately one in eight individuals who experience
traumatic life events develop PTSD (Kessler et al., 1995), we will
place particular emphasis on individual differences in PTSD and
the need for animal models to consider this variation in studies
of risk and resilience. Finally, to encourage direct investigation of
epigenetic mechanisms in animal models of PTSD, we will provide
a brief technical overview of the rapidly evolving approaches for
measuring DNA methylation that can serve as a launching pad for
researchers interested in applying these tools to their own work.
Overall, we will explore the idea that trauma induces long-lasting
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epigenetic changes that mediate PTSD-associated outcomes, and
that the exact changes elicited are influenced by individual-specific
epigenetic landscape on which the traumatic event occurs.
OVERVIEW OF EPIGENETICS IN PTSD
Post-traumatic stress disorder is a multifaceted disorder that
involves the deregulation of stress-responsive endocrine sys-
tems and of neurotransmitters and neuromodulators involved in
arousal, depression, and anxiety (Baker et al., 2012). Although
studies focused on identifying the relative contributions of these
various systems have shaped the current understanding of the bio-
logical basis of PTSD, further progress will be driven by identifying
common factors that drive and maintain their deregulation. Epi-
genetic modifications are emerging as one such factor because of
their role in mediating gene expression for various components of
the endocrine system, signaling molecules, and transcription fac-
tors (Champagne et al., 2006;Weaver et al., 2007; Chang et al., 2012;
Russo et al., 2012; Klengel et al., 2013). In turn, epigenetic modi-
fications are themselves regulated by upstream signaling cascades
that converge to mediate epigenetic modifications in the nucleus,
whereas existing epigenetic states alter the efficacy of the upstream
signaling cascades on gene expression and behavior (Levenson
et al., 2004; Fischer et al., 2007; Roozendaal et al., 2010; Graff and
Tsai, 2011; Graff et al., 2011). In addition to providing an inte-
grated perspective on psychiatric disorders, this bidirectionality
offers promise for epigenetically based pharmacotherapies, which
can reduce the threshold for, and amplify the response to, upstream
signals (Graff and Tsai, 2011).
EPIGENETIC MECHANISMS
DNA methylation initially gained notoriety for its role in the
maintenance of cellular identity and heritable changes in gene
expression throughout the cell cycle. DNA is initially methylated
at the 5′ position of the cytosine–pyrimidine (5mC) ring byde novo
DNA methyltransferase enzymes DNMT3a and 3b (Chiang et al.,
1996; Turker, 1999; Bird, 2002; Cheng et al., 2010). This pattern of
methylation is maintained throughout cell division by the mainte-
nance DNMT1, which methylates cytosines opposite a methylated
strand to allow for self-perpetuation of DNA methylation across
cell divisions (Santos et al., 2005; Cheng et al., 2010). Given the
energetic cost of removing a covalent 5mC bond and its role in the
maintenance and propagation of cellular identity, 5mC was clas-
sically considered to be an irreversible mark. This notion has held
largely true for the maintenance of cell-specific gene expression,
but the classical view was challenged by evidence of active DNA
demethylation in response to environmental stimuli in the brain,
estrogen stimulation in cultured cells, and in muscle after exercise
(Levenson et al., 2006; Miller and Sweatt, 2007; Kangaspeska et al.,
2008; Metivier et al., 2008; Barres et al., 2012).
Indeed, 1.4% of measured CpGs (cytosines adjacent to gua-
nines) in the granule cells in the dentate gyrus of the hippocampus
exhibited altered DNA methylation in response to neuronal acti-
vation (Guo et al., 2011a), indicating that active DNA methylation
and demethylation are a normal outcome of neuronal activity.
Mechanisms of active DNA demethylation have been elusive, with
limited success of early efforts to identify enzymes that remove
5mC directly. However, recent studies have provided a flurry
of evidence suggesting that active demethylation is a stepwise
process in which modifications of 5mC create a base mismatch
that is replaced by an unmethylated cytosine through base exci-
sion repair (BER) (Wu and Zhang, 2010). Oxidation of 5mC to
5-hydroxymethylcytosine (5hmC) has emerged as a key step in
active DNA demethylation in the brain and is accomplished by
the ten-eleven translocation (TET) family of methyl-cytosine-
dioxygenases (Tahiliani et al., 2009; Guo et al., 2011b; Ito et al.,
2011). The resulting 5hmC is further modified by AID/APOBEC
deaminases to yield 5 hydroxymethyluridine (5hmU) that is rec-
ognized by TDG and MBD4 to generate apurinic/apyrimidinic
(AP) sites, which are cleaved by AP endonucleases and subjected
to BER for replacement with an unmodified cytosine (5mC) (Ma
et al., 2009a,b; Fritz and Papavasiliou, 2010; Bhutani et al., 2011;
Guo et al., 2011b; Niehrs and Schafer, 2012; Grayson and Guidotti,
2013). Gadd45 proteins have also been implicated in this process,
presumably by linking the AID/APOBEC deaminases with glyco-
sylases to promote BER, which is particularly relevant for activity
induced demethylation given the high sensitivity of Gadd45 to
neural activity (Ma et al., 2009a,b). The much higher abundance
(10-fold) of 5hmC in the rodent and human brain relative to other
tissues (Kriaucionis and Heintz, 2009; Munzel et al., 2010; Jin et al.,
2011; Szulwach et al., 2011), its increased levels over development
(Munzel et al., 2010; Song et al., 2011b), and its regulation by neu-
ronal activity (Guo et al., 2011b), suggest that this modification
may be particularly relevant for cognitive function.
DNA methylation was initially identified as a mechanism for
persistent repression of gene activity by the recruitment of co-
repressor complexes (Karymov et al., 2001; Drewell et al., 2002)
and the direct interference of 5mC with binding of transcriptional
machinery (Iguchi-Ariga and Schaffner, 1989) to gene promoters.
However, recent studies have shown that this is not always the
case and that 5mC may at times be associated with gene activa-
tion. For example, although DNMTs are traditionally implicated in
gene silencing (Chen et al., 2002), DNMT3a2 was recently associ-
ated with gene activation and improved cognitive function (Kotini
et al., 2011) and de novo DNMTs may even be involved in DNA
demethylation (Chen et al., 2012a). New evidence also suggests
that the effect of DNA methylation on transcription may depend
on the specific site on which the modification occurs, with 5mC at
gene promoters and regulatory elements promoting gene repres-
sion and 5mC in gene bodies promoting gene activity (Hellman
and Chess, 2007; Zilberman and Henikoff, 2007; Maunakea et al.,
2010; Shenker and Flanagan, 2012). Although gene repression has
been associated with the methylation of CpG islands in gene pro-
moters, recent studies suggest that only 6.8% of CpGs are found
in CpG islands (Rollins et al., 2006) and CpG islands are not ubiq-
uitous to all human promoters (Deaton and Bird, 2011). In fact,
newly identified CpG-island flanking regions termed CpG shores
exhibit comparatively low CpG density and higher variability in
methylation in cancer compared to CpG islands (Irizarry et al.,
2009), implicating these sites in gene regulation. It is not clear
to what extent these site-dependent functional differences are
attributable to 5mC compared to 5hmC, since recent studies have
demonstrated that 5hmC is depleted from promoters and inter-
genic regions and is enriched in gene bodies of actively transcribed
cerebellar genes (Mellen et al., 2012). In contrast, a 5hmC peak that
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appeared 900 bp 5′ of the transcription start site was not correlated
with transcription (Mellen et al., 2012), perhaps suggesting an
alternative function. Of note, 5mC in the latter study was depleted
from the bodies of actively transcribed genes and there was a ten-
dency for a negative association between intragenic 5mC and gene
expression in some cell types more than others (Mellen et al.,
2012). Overall, however, intragenic 5hmC:5mC ratio was a better
predictor of gene expression than 5mC or 5hmC alone (Mellen
et al., 2012), pointing to the importance of considering both mod-
ifications in relation to transcription in different cell types. More
broadly, these data indicate that the role for DNA methylation is
more heterogeneous than initially suspected and that further stud-
ies will be required to fully understand the relationship between
DNA methylation and transcription.
Many effects of DNA methylation are exerted through inter-
actions with DNA-binding factors that recruit co-activators or
co-repressors to mediate gene transcription and post-translational
modifications (PTMs) of histones (Strahl and Allis, 2000; Ooi et al.,
2007; Borrelli et al., 2008). DNA is packaged into nucleosomes,
which are the building blocks of chromatin and are composed
of ∼147 bp of DNA wrapped around an octamer of 2 each of
histones H2A, H2B, H3, and H4 (Quina et al., 2006). Histones
are critical regulators of DNA accessibility and chromatin com-
pression or openness is determined in part by PTMs of histones
(Strahl and Allis, 2000). Histones contain protruding tails that can
be modified in a number of ways, most notably through acetyla-
tion, methylation, and phosphorylation (Strahl and Allis, 2000).
As with DNA methylation, the pattern of histone modifications
appears to differ based on the genomic region of interest, notably
between introns and exons and around the transription start site
(TSS) (Lieb and Clarke, 2005; Zilberman and Henikoff, 2007; Choi
et al., 2010; Huff et al., 2010).
Of these various chromatin modifications, histone acetylation
has received the most attention and is typically involved in the
activation of gene expression (Mujtaba et al., 2007), whereas his-
tone methylation can be involved in either activation or repression
(Nakayama et al., 2001; Peters and Schubeler, 2005). Histone acety-
lation is catalyzed by histone acetyltransferases (HATs) and the
reverse deacetylation reaction is performed by a large number of
histone deacetylases (HDACs) (Hebbes et al., 1988; Wade, 2001).
The binding of these enzymes is influenced by DNA methyla-
tion and associated methyl-CpG binding proteins, particularly
MeCP2, which recruits HDACs to gene promoters to facilitate
histone deacetylation (Lorincz et al., 2004; Liu et al., 2005). Recent
evidence from the model plant Arabidopsis thaliana and from
treatment with the HDAC inhibitor (HDACi) valproic acid (VPA)
suggests that the reverse reaction may also be true, with HATs par-
ticipating in DNA demethylation (Tremolizzo et al., 2002, 2005a,b;
Detich et al., 2003; Qian et al., 2012). Indeed, the methyl-CpG
binding protein MeCP2 interacts with CREB to promote histone
acetylation (Chahrour et al., 2008), although it is not clear whether
this relationship occurs through MeCP2 interactions with 5hmC
and 5mC (Mellen et al., 2012).
MeCP2 binds to both 5mC and 5hmC in the cerebellum,
but binding at 5hmC was associated with accessible chromatin
and gene activation, whereas binding at 5mC was associated
with closed chromatin and gene repression (Mellen et al., 2012).
These effects were mediated by different residues on MeCP2,
with a mutation in R133C preferentially altering binding to
5hmC compared to 5mC (Mellen et al., 2012). Other have
also reported chromatin-regulating effects of neurally expressed
MeCP2, with a weak association of MeCP2 with open chromatin
and a strong association with closed chromatin (Thambirajah
et al., 2012). Overall, there is some overlap in DNA-binding
factors that interact with 5mC and 5hmC, but each modifica-
tion also has unique interacting partners and different affinities
for certain MBDs and other DNA-binding proteins (Hashimoto
et al., 2012; Spruijt et al., 2013). These data suggest that 5hmC
may be a transcriptional regulator in its own right rather than
having a sole function as an in intermediary in active DNA
demethylation.
The rapid advancements in techniques for detecting 5mC and
5hmC (see Box 1) and the application of whole-genome sequenc-
ing approaches have led to an unprecedented rate of growth in our
understanding of epigenetic mechanisms in the regulation of gene
expression. The wealth of new information has challenged many of
the classical views of epigenetics in general and DNA methylation
in particular, with many important implications for interpreting
past and future data in the field. The most direct lesson from
recent studies is that epigenetic modifications have diverse roles
in gene regulation and that their effect on gene expression can-
not be directly inferred from examining epigenetic modifications
alone.
Although we have focused heavily on DNA methylation, even
the typically activating histone acetylation mark has been found
on bivalent promoters that can be either activated or repressed
(Lin et al., 2007; Vastenhouw and Schier, 2012) and HATs and
HDACs tend to colocalize on the same genomic sites (Peserico
and Simone, 2011). Similarly, in addition to their role in oxidation
of 5mC to 5hmC, TET proteins may have additional regulatory
roles, as exemplified by TET1 interaction with a repressive com-
plex that might have a role in gene repression independent of its
role in DNA demethylation (Bhutani et al., 2011; Ito et al., 2011;
Wu and Zhang, 2011; Williams et al., 2012).
Another critical point is that many of the earlier studies did
not distinguish between 5mC and 5hmC, making it difficult
to draw inferences regarding the relative contribution of each.
Although many approaches have been developed to differenti-
ate the two, many techniques still encompass both modifications
(see Box 1). Finally, growing evidence for distinct functions of
DNA methylation at different genomic sites indicates that the
common approach of using a single primer per gene may not
be sufficient to detect changes in DNA methylation, or that the
direction of the change may depend on the region studied (i.e.,
intragenic vs. promoter; CpG island vs. CpG-island shore). One
solution to this approach is to do whole-genome sequencing,
although a cost effective alternative is to utilize multiple primers
to represent different regions relevant for detecting functional
effects. An additional confound in neurobiology is the difficulty
in distinguishing between epigenetic modifications occurring in
neurons and glia, which will require more wide-spread use of
cell sorting approaches and neuron-specific labels to improve
our understanding of epigenetic changes in these distinct cell
types.
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Box 1 Review of tools for measurement of hydroxymethylation.
Global 5hmC analysis
Several options exist for the global quantification of nucleotide variants implicated in epigenetic regulation, which include 5-methylcytosine
(5mC), 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), and 5-carboxylcytosine (5caC), respectively. Currently, various antibodies
raised against these epigenetic markers are available (Inoue et al., 2011; Ito et al., 2011) and have been employed in combination with either
an enzyme-linked immunosorbent assay (ELISA) or dot-blot analysis for global detection (Koh et al., 2011; Li and Liu, 2011). In addition, some
have taken advantage of the enzymeT4 phage β-glucosyltransferase (T4-GβT) and its ability to specifically add glucose to 5hmC to generate
β-glucosyl-5-hmC (5gmC) (Terragni et al., 2012). Using this process, a radio-labeled glucose can then be transferred to 5hmC for sensitive
and accurate detection of its global levels (Lian et al., 2012).
Another strategy to identify nucleotide modifications involves the use of thin layer chromatography (TLC) coupled with radio labeling.This
approach provides a high level of sensitivity and was implemented by several labs leading to the initial discoveries of both 5hmC (Kriaucionis
and Heintz, 2009;Tahiliani et al., 2009) and 5caC (He et al., 2011; Ito et al., 2011), respectively. However, of all the methods mentioned above,
the gold standard remains the use of liquid chromatography (LC) followed by MS to resolve and precisely measure nucleosides containing
these epigenetic marks (Globisch et al., 2010; Munzel et al., 2010; Ito et al., 2011).
Loci specific analysis and 5hmC enrichment
hMeDIP: A number of methods are now available for the measurement of 5hmC levels at the resolution of individual genomic loci.
The first, hydroxymethyl-DNA immunoprecipitation (hMeDIP) requires the enrichment of 5hmC-containing DNA, typically with an antibody
raised against 5hmC or its sodium bisulfite converted derivative, 5-methylsulfonate (CMS) (Pastor et al., 2011). Alternatively, enrichment
can be achieved through T4-GβT-mediated conversion of 5hmC to 5gmC, followed by incubation with J-binding protein-1 (JBP-1); a protein
shown to have a strong affinity for the modified base (Robertson et al., 2011). Likewise, some groups have gone on to process 5gmC even
further through oxidation and biotinlyation steps (Pastor et al., 2011) (GLIB) or with selective chemical labeling (Song et al., 2011a) (hMe-Seal),
allowing for the enrichment of biotinylated 5hmC residues using streptavidin beads. Using either the GLIB or hMe-Seal strategies allow for
improved hMeDIP fidelity as well as the enrichment of genomic regions containing low amounts of 5hmC.
Restriction enzyme digestion: Recently, a number of restriction enzymes whose activity is blocked either by 5hmC itself or after
5hmC glycosylation have been characterized (Zheng et al., 2010; Cohen-Karni et al., 2011; Davis and Vaisvila, 2011; Kinney et al., 2011;
Song et al., 2011b; Szwagierczak et al., 2011; Wang et al., 2011; Xu et al., 2011). The latter of these enzymes have been termed glucosyl-
5-hydroxymethylcytosine sensitive restriction endonucleases (GSREs) and several companies now offer commercial kits to investigators.
Due to their unique properties, these enzymes can be used to identify specific 5hmc-containing loci provided the region of interest contains
the enzymes recognition site. Difficulties arising due to lack of compatible restriction endonuclease recognition sites in genomic regions of
interest may be overcome using several different GRSEs. This technique has been further extended using several GSREs in combination,
which enables the determination of both 5hmC and 5mC content at the same genomic location (Davis and Vaisvila, 2011).
Both techniques outlined here are amenable for analysis using quantitative PCR analysis for 5hmC detection at individual loci or for
whole-genome profiling, microarray analysis, and next generation sequencing.
Single-base resolution sequencing
Although hMeDIP and GRSE analysis can both be useful tools for the analysis of 5hmC distribution on a genome-wide scale, they are limited
in their resolution due to DNA fragmentation size and capture technology. To overcome these limitations, several groups have developed
techniques to achieve the sequencing of 5hmC residues at a single-base resolution.The first involves the use of third-generation sequencing
technology called single-molecule, real-time (SMRT) sequencing which monitors the incorporation of individual nucleotides by DNA poly-
merase in real time (Eid et al., 2009) and can detect DNA base modifications like 5mC and 5hmC compared to unmodified cytosine due to
changes in DNA polymerase kinetics (Flusberg et al., 2010).This technique has now been combined with hMe-Seal to chemically label 5hmC
in an effort to distinguish it further from 5hmC and C during DNA polymerization (Song et al., 2012). A second method termed oxidative bisul-
fite sequencing (oxBS-Seq) involves comparison of a traditional bisulfite sequenced sample (BS-seq) to that which has undergone oxidative
conversion of 5hmC to 5fC, prior to bisulfite conversion (Booth et al., 2012). While BS-seq can convert both 5mC and 5hmC to cytosines
(Cs), oxBS-Seq only allows for conversion of 5mC sites to Cs.Thus, the amount of 5hmC present at a particular nucleotide position can then
be determined by subtraction of the oxBS-Seq sample from that of the BS-Seq sample. Finally, Tet-assisted bisulfite sequencing (TAB-seq)
is a technique which combines the protection of 5hmC by T4-GBT glycosylation with Tet-mediated oxidation of 5mCs to 5caCs (Yu et al.,
2012). After bisulfite conversion all 5caCs are converted to Ts, leaving only protected 5hmC residues as Cs, resulting in a straight-forward
interpretation of 5hmC data at a base-by-base resolution.
ANIMAL MODELS
Well-designed animal models are critical for uncovering epige-
netic mechanisms of PTSD by allowing for the control of the
temporal parameters needed to understand predisposition, onset,
maintenance, and treatment of the disorder. An appropriate ani-
mal model must ensure face and etiological validity by mimicking
the conditions of the disorder seen in human patients, which
primarily involves exposure to a traumatic event in the case of
PTSD (van der Staay et al., 2009). The traumatic event has been
modeled in a number of ways, including exposure to an aversive
shock in fear conditioning, exposure to a predator, social defeat,
restraint, or underwater holding (Adamec and Shallow, 1993;
Richter-Levin, 1998; Cohen et al., 2000a,b; Siegmund and Wot-
jak, 2007; Zoladz et al., 2008; Zovkic and Sweatt, 2013). Given
the association between trauma and symptom severity in human
patients (Koenen and Uddin, 2010; Uddin et al., 2010), stimuli
that can deliver graded levels of trauma are preferred in an ani-
mal model (Siegmund and Wotjak, 2007). Shock delivery in fear
conditioning is particularly amenable to manipulating gradations
in stimulus intensity and duration (Siegmund and Wotjak, 2007),
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although different degrees of trauma intensity can also be achieved
in predator exposure models by exposing rodents to cat odor alone,
a caged cat, or to a direct encounter with a cat (Zoladz et al., 2008;
Goswami et al., 2012). The etiological validity of these models
can be further improved by combining the traumatic experience
with additional risk factors that further enhance vulnerability to
PTSD, such as the lack of social support and persistent exposure
to chronic mild stress (Zoladz et al., 2008). In one example, the
number of rodents expressing PTSD symptoms was increased by
combining predator odor exposure with 31 days of social instabil-
ity stress in an effort to mimic the lack of social support seen in
individuals vulnerable to PTSD (Zoladz et al., 2008).
As an extension of the face validity criterion, animal models
must include dependent variables that parallel the diverse symp-
toms of PTSD in order to generate testable predictions for research
and treatment in human patients (van der Staay et al., 2009).
PTSD patients exhibit a wide range of symptoms, including hyper-
arousal, increased startle, emotional blunting, and social with-
drawal, which can be included as outcome variables in response to
a variety of traumatic stimuli (Siegmund and Wotjak, 2007; Uddin
et al., 2010; Skelton et al., 2012). These symptoms are induced by
fear conditioning and predator exposure models of PTSD and
are typically assessed after a prolonged stress-free period (Zovkic
and Sweatt, 2013). For example, fear conditioning can be used
to assess intensity-dependent freezing upon re-exposure to the
training context to test for the expression of associative fear and
upon exposure to a novel, neutral tone to provide an index of
non-associative fear sensitization, hyperarousal, and startle (Sieg-
mund and Wotjak, 2007). Importantly, the expression of sensitized
fear to a novel auditory cue was found to increase with time after
shock exposure (Siegmund and Wotjak, 2007), which is particu-
larly important in light of the proposed revisions to DSM-V that
emphasize delayed symptom onset over the initial fear response
(Resick and Miller, 2009; Friedman et al., 2011a,b). Indeed, many
patients who are diagnosed with PTSD show little to no emo-
tional response upon initial exposure to trauma, with symptoms
developing only with the passage of time (Shalev et al., 2000; Grif-
fin, 2008; Friedman et al., 2011a,b). Associative fear is particularly
amenable to delayed behavioral assessment (Miller et al., 2010)
and has the advantage of modeling the re-experiencing of fear in
PTSD patients by presenting animals with an aversive cue or con-
text without the need for re-exposure to the traumatic stimulus
(i.e., footshock) (Zovkic and Sweatt, 2013).
MODELS OF PREDISPOSITION TO PTSD
A difficulty with PTSD studies in humans is the poor ability to
distinguish between pre-existing risk factors and trauma-induced
outcomes. Co-twin studies, in which only one twin has experi-
enced trauma, found that certain parameters that were thought
to be caused by trauma may actually be pre-existing risk factors
for PTSD, including impaired cognitive function and reduced hip-
pocampal volume (Kremen et al., 2012). It can also be difficult to
separate out epigenetic outcomes from epigenetic risk factors in
non-controlled studies of human patients, although cumulative
effects of trauma on DNA methylation of immune system genes
suggest that traumatic experiences are key drivers of epigenetic
outcomes in this scenario (Uddin et al., 2010).
Animal models can be particularly valuable in this regard by
evaluating temporal parameters of variables identified in human
studies to determine their relative role in conferring risk for PTSD
or outcomes of trauma. An evaluation of individual differences
is a key component for the success of such models (Yehuda and
Bierer, 2009). The emphasis of animal models of PTSD tends to be
on the stress exposure (induction) and the associated depressive
and anxious phenotypes (read out), which are valuable tools for
defining the cognitive, molecular, and neuroanatomical outcomes
of stress exposure, but are less productive in explaining the rel-
atively low incidence of persistent psychopathology in response
to trauma (Yehuda et al., 2006). Individual differences in rodents
can be investigated by classifying animals according to natural
variation in behavior, by utilizing genetic predictors of risk and
selective breeding strategies based on traits associated with risk and
resilience (Scharf and Schmidt, 2012). Cohen and Zohar (2004)
developed a model of classifying rodents according to natural
variation in responses to predator exposure, in which ∼22% of
the rats meet the PTSD criteria based on behavioral, endocrine,
and sympathetic markers. The ad hoc classification system used
in these studies is extremely useful for understanding long-term
adaptations in behavioral and molecular systems that distinguish
vulnerable and resilient individuals after trauma, but such mod-
els do not provide any information on the source of vulnerability
or resilience before trauma (Siegmund and Wotjak, 2007; Zovkic
and Sweatt, 2013). Selective breeding of vulnerable and resilient
mice can help circumvent this problem by allowing for the assess-
ment of pre-existing differences prior to trauma (Siegmund and
Wotjak, 2007). For example, strain differences have been noted
between PTSD vulnerable B6N and the resilient B6JOla mice,
with B6N exhibiting blunted affect and reduced sociability in the
absence of any exposure to trauma (Siegmund and Wotjak, 2007).
Genetic mouse models can also be used to evaluate the role of risk
genes identified in human studies and these models can be com-
bined with developmental stressors to probe for gene-environment
interactions at distinct stages of development.
History of stress exposure, particularly in early life, is another
essential factor in predisposing individuals to PTSD in adulthood
(Scharf and Schmidt, 2012). Although most rodent studies of early
environment do not relate behavioral and biochemical outcomes
to PTSD directly, their relevance to PTSD has been widely rec-
ognized because of the emphasis on the stress-responsive neural
circuitry and the related behavioral outcomes (Yehuda and Bierer,
2009).
A widely studied model utilizes variation in maternal licking
and grooming (LG) and arched back nursing (ABN) of pups as
an index of early life experience. In this model, the offspring of
high LG-ABN mothers are less anxious and responsive to stressors
compared to the offspring of low LG-ABN dams (Weaver, 2009).
However, the extent to which one maternal style is“better”than the
other is not clear, as the offspring of high and low LG mothers may
each be better adapted to different environmental circumstances
(Bagot et al., 2009). However, the offspring of low LG mothers are
phenotypically similar to the pups that underwent maternal sep-
aration stress (≥3 h separation) and high LG offspring are similar
to those who underwent a milder brief separation (15 min), often
referred to as handling, in the first 7–14 days of life (Anisman et al.,
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1998; Francis et al., 2002; Wilber and Wellman, 2009), indicating
that low LG-ABN is akin to a more stressful upbringing. Utiliza-
tion of maternal maltreatment models with an unambiguous stress
exposure in early life (Roth and Sweatt, 2011) will be particularly
useful in clarifying the association between stressful upbringing
and behavior. Moreover, combining these early life models with
adult models of PTSD (Cohen and Zohar, 2004) can provide
critical information regarding the interaction between early life
experience and the later risk and resilience for PTSD.
PTSD AND THE HPA AXIS
THE HPA AXIS
Many studies of individual differences in risk and resilience
have focused on the hypothalamic-pituitary-adrenal (HPA) axis
because of its central role in adaptation to stress. The diagnosis
of PTSD requires that symptom onset be preceded by a traumatic
event and PTSD was recently reclassified as a traumatic and stress-
related disorder instead of an anxiety disorder in the newly released
DSM-V (Friedman et al., 2011a,b). Stressful encounters induce
the release of corticotropin releasing hormone (CRH) from the
hypothalamus into the pituitary gland to stimulate the release of
adrenocorticotropin hormone (ACTH) and activate the release of
glucocorticoids (GCs; cortisol in people, corticosterone in rodents)
from the adrenals (Novak et al., 2013). The acute GC response
allows individuals to deal with stressors by mobilizing resources,
adjusting heart rate, and regulating immune function in the short
term, whereas deregulation of GC release over prolonged time
periods is detrimental to health, mood, and cognition (Sorrells
and Sapolsky, 2007).
GC receptors (GR) are found throughout the brain and are
particularly abundant in the hippocampus, where they influence
memory formation, cognitive function, and initiate negative feed-
back to reinstate baseline GC levels after stress (Novak et al., 2013).
The HPA axis is a critical regulator of the response to trauma in
adults and the deregulation of this response has been implicated
in the development of PTSD (Yehuda et al., 2004, 2009). PTSD
patients generally exhibit reduced levels of GCs, increased negative
feedback, abnormal GR expression, and higher levels of CRH com-
pared to non-traumatized controls (Yehuda et al., 2002; Rohleder
et al., 2004; de Kloet et al., 2008), indicating that a blunted GC
response to stress may be a risk factor for PTSD (Yehuda and
McFarlane, 1995; Yehuda and LeDoux, 2007).
Exposure to GCs stimulates a range of epigenetic modifica-
tions that are though to be mediated by the GR (Roozendaal et al.,
2010; Yang et al., 2012). The GR is a transcriptional regulator
that translocates to the nucleus upon ligand binding, where it
activates or represses transcription through actions on the gluco-
corticoid response element (GRE) (Cairns et al., 1991). According
to some estimates, GCs regulate between 1000 and 2000 genes in
cortical neurons (Kino, 2007; Sun et al., 2008) and chronic stres-
sors regulate gene expression and histone modifications in neural
regions associated with cognitive function, affect, and motivation
(Tsankova et al., 2004, 2006; Covington et al., 2011a,b). Effects of
GR on transcription are closely tied to epigenetic regulation, as
exposure to stress or treatment with glucocorticoids results in the
persistent and gene-specific demethylation of GREs in peripher-
ally derived human cells and the rodent brain (Unternaehrer et al.,
2012; Yang et al., 2012; Klengel et al., 2013). In addition, exposure
to stress in early life alters the expression of epigenetic regula-
tors themselves, as evidenced by increased levels of DNMT3a in
the placenta and the brain of pups of stressed mothers (Jensen
Pena et al., 2012). Moreover, maternal maltreatment and natural
variation in maternal care induce modifications of DNA methy-
lation and expression of target genes that persist into adulthood
in the rodent brain (Weaver et al., 2002; Zhang et al., 2006; Roth
and Sweatt, 2011). In addition to the direct effects of GR in the
nucleus, the GR mediates histone acetylation at target genes indi-
rectly through the activation of the PKA-pCREB/CBP pathway via
its membrane-bound receptor (Roozendaal et al., 2010). Overall,
these studies demonstrate the ability of stressors to regulate epige-
netic modifications, presumably through the actions of GCs on the
GR receptor, although other potential pathways, such as sympa-
thetic and noradrenergic responses, cannot be ruled out (Geracioti
et al., 2001; Bierer et al., 2006; Videlock et al., 2008).
In addition to regulating epigenetic modifications, the HPA
axis is itself epigenetically regulated, particularly during devel-
opment, when the GR, CRH, and the GC inactivating enzyme
HSD11B2 exhibit persistent alterations in DNA methylation and
gene expression in response to maternal stress and natural varia-
tion in maternal behavior (Weaver, 2009; Roth and Sweatt, 2011;
Jensen Pena et al., 2012). It has been shown, for example, that
maternal deprivation between postnatal days 2 and 13 leads to
hypomethylation of the cyclic AMP-response element (CRE) in the
CRH promoter in the hypothalamus (Chen et al., 2012b), which is
particularly relevant given the higher levels of CRH in patients with
PTSD (de Kloet et al., 2008). Similarly, offspring of low LG mothers
exhibit higher GR methylation, reduced GR expression, and higher
reactivity to stress and anxiety in adulthood compared to the off-
spring of high LG mothers (Weaver,2009). This effect is established
in the first 7 days of life, when high levels of LG induce increased
NGFI-1 expression, an upregulation of histone acetylation, and a
decrease in DNA methylation at the NGFI-1 binding site of the
GR promoter (Weaver et al., 2002, 2004a; Weaver, 2009). Extensive
individual differences in DNA methylation of the GR promoter
have been reported in people and include increased methylation
of the NGFI-1 binding site on the GR promoter and decreased GR
expression in the hippocampus of suicide victims with a history
of childhood abuse compared to non-abused suicide victims or
controls (McGowan et al., 2009).
It thus appears that elevated activity of DNA-binding mol-
ecules, such as GR and NGFI-I, may regulate binding to their
respective response elements by reducing DNA methylation at
the appropriate sites. This relatively well characterized system of
maternal regulation of GR expression illustrates the close bidirec-
tional relationship between epigenetic mechanisms and upstream
signaling cascades. Moreover, the observation that persistent epi-
genetic changes are established in the first 7 days of life (Szyf et al.,
2007) suggests that long-lasting effects of stress, maternal behavior,
and GC exposure are amplified during sensitive periods of devel-
opment, although the GR promoter is also subject to epigenetic
regulation in adulthood (Witzmann et al., 2012).
Depending on the type of maternal care, epigenetic program-
ing of GC release and GR expression may promote vulnerable
or resilient phenotypes in adulthood (Dudley et al., 2011). On
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the surface, some parallels can be drawn between high LG moth-
ers and the children of Holocaust survivors who had lower levels
of GCs and rated their mothers as overprotective (Yehuda and
Bierer, 2009). Based on such evidence, Yehuda and Bierer (2008)
argued that reduced GC levels in high LG offspring parallel reduced
cortisol, increased lymphocyte GR expression, and increased GR
sensitivity seen in human PTSD patients (Yehuda et al., 1998, 2002;
Yehuda, 2002a,b), although others interpret the reduced cortisol
response to stress as protective (Barha et al., 2007). However, there
are also reports of reduced levels of GR in leukocytes of PTSD
patients (de Kloet et al., 2007), which parallels the reduced levels of
GR density seen in low LG offspring. Furthermore, prenatal mater-
nal depression/anxiety leads to increased methylation within the
GR promoter at a predicted NGFI-A binding site in infants (Ober-
lander et al., 2008), likely leading to an overall reduction in GR
expression. It is difficult to draw comparisons based on circulating
GC and peripheral GR levels alone and studies of GR density in
post-mortem brains of PTSD patients are needed to draw clearer
parallels. The contention that the offspring of high LG mothers
exhibit parallel HPA axis activity to PTSD patients (Yehuda and
Bierer, 2009) is consistent with the view that some stress exposure
at distinct stages of development confers resilience to PTSD in
adults through “stress inoculation” (Ricon et al., 2012). Given the
phenotypic similarities between outcomes associated with mater-
nal separation stress and low LG offspring (Anisman et al., 1998;
Francis et al., 2002; Wilber and Wellman, 2009), the concept of pro-
tective effects of “stress inoculation” (Ricon et al., 2012), and the
adaptive function of an appropriate GC response to stress (Yehuda
and McEwen, 2004), some have suggested that low LG offspring
are actually better adapted to deal with stressful environments than
high LG offspring (Bagot et al., 2009).
GENE× ENVIRONMENT× EPIGENOME INTERACTIONS
Individual differences in adult risk and resilience to PTSD are
shaped by a combination of genetic and environmental factors.
Although genes and environment can produce shifts in risk and
resilience on their own, the strongest phenotypic effects are asso-
ciated with gene-environment interactions that are mediated by
epigenetic modifications (Caspi and Moffitt, 2006; Chertkow-
Deutsher et al., 2010; Dudley et al., 2011; Russo et al., 2012; Klengel
et al., 2013; Zovkic and Sweatt, 2013). Environmental factors are
particularly influential during early life, when they interact with
epigenetic mechanisms to lastingly alter the expression of a broad
range of genes (Sundermann et al., 2012, 2013).
Studies of stress exposure in rodent strains with differential sus-
ceptibility to risk and resilience have reported distinct epigenetic
and behavioral outcomes, although the specific genes involved
in mediating these effects have not been identified. For example,
vulnerable BALB/c (BALB) mice exhibited differences in H3 acety-
lation and DNA methylation of the glial cell-derived neurotrophic
factor (GDNF) in the nucleus accumbens compared to the resilient
C57BL/6 (B6) mice (Uchida et al., 2011). In addition, BALB mice
showed a specific increase in MeCP2-HDAC2 association and B6
showed an increase in MeCP2-CREB association at the GDNF
promoter, which were associated with increased and decreased
GDNF expression in B6 and BALB mice, respectively. Vulnera-
bility and resilience were also associated with opposite changes
in DNA methylation of the same genes (Elliott et al., 2010), and
with different levels of intronic DNA methylation and expression
of dlgap2, a gene coding for PSD95 (Chertkow-Deutsher et al.,
2010). In contrast, rodents classified as vulnerable or resilient
based on behavioral responses to acute unavoidable stress exhib-
ited differential regulation of distinct genes, with upregulation
of neuroendocrine-related genes, growth hormone, and prolactin
genes in vulnerable rats, and the downregulation of interferon-β
and leukemia inhibitory factor in the frontal cortex of resilient
rats (Benatti et al., 2012). Furthermore, Oh et al. (2013) found
that an adverse maternal environment in rodents was associated
with differentially methylated sites that clustered in the bod-
ies of genes associated with cell adhesion and neurotransmitter
receptors in the hippocampus. Finally, a study investigating the
effects of environmental stress in non-human primates found an
association between increased stress reactivity and higher overall
methylation (Kinnally et al., 2011), which led them to specu-
late that the overall increase in methylation constrained plastic-
ity through gene repression. However, the degree to which this
hypothesis will hold true in light of evidence for an activating
role of DNA methylation remains to be determined. Overall, these
studies demonstrate that similar environmental experiences can
produce extremely different outcomes through epigenetic inter-
actions with individual-specific factors that mediate vulnerability
and resilience.
THE HPA AXIS
Studies of human patients have found genotype-specific effects of
early environment on adult risk for PTSD to be mediated by epige-
netic modifications of genes associated with the HPA axis (Koenen
and Uddin, 2010; Ressler et al., 2011; Klengel et al., 2013). Fkbp5 is
a negative regulator of GR activity that has received much atten-
tion in this regard, in part because of reduced Fkbp5 and cortisol
levels in the patient population (Yehuda and Bierer, 2009; Yehuda
et al., 2009; Koenen and Uddin, 2010; Klengel et al., 2013). Single
nucleotide polymorphisms (SNPs) in the Fkbp5 gene are associ-
ated with predisposition to PTSD, wherein the same allele confers
either risk or resilience in the presence or absence of childhood
adversity, respectively (Xie et al., 2010). Specifically, SNPs around
the GRE in the human Fkbp5 gene increased risk for PTSD only
in individuals who experienced childhood trauma (Binder et al.,
2008; Yehuda et al., 2009). This effect was epigenetically medi-
ated, in that GC exposure was associated with greater Fkbp5 GRE
demethylation and higher Fkbp5 expression in carriers of the risk
compared with the protective allele (Klengel et al., 2013). These
data are in contrast to reports of reduced Fkbp5 expression in
PTSD patients (Yehuda et al., 2009), but the discrepancy may in
part be explained by variability across peripherally derived cell
types and the sorting of data according to genetic variation.
PAC1R, a receptor for PACAP (pituitary adenylate cyclase-
activating peptide), is another gene involved in stress respon-
siveness that has been implicated in PTSD (Dias and Ressler,
2013). PACAP is elevated in the blood of female, but not male,
patients with PTSD and an SNP in the estrogen response ele-
ment of the PAC1R gene interacts with trauma to mediate risk
for PTSD in affected individuals (Ressler et al., 2011). Moreover,
DNA methylation of the PAC1R gene is positively associated with
www.frontiersin.org June 2013 | Volume 4 | Article 60 | 7
Zovkic et al. Epigenetics in PTSD
PTSD (Ressler et al., 2011), again emphasizing the role of epige-
netic factors as mediators of gene-environment associations. These
data provide critical insights into the factors involved in establish-
ing vulnerable phenotypes during development, but comparisons
of epigenetic responses in vulnerable and resilient adult rodents
are required to understand how traumatic experiences produce
different outcomes in those individuals.
SYNAPTIC PLASTICITY AND NEUROTRANSMITTER GENES
In addition to the HPA axis, gene-environment-epigenome inter-
actions have been reported for neuromodulators, neurotrans-
mitters, and other molecules relevant for synaptic function and
plasticity. For example, the serotonergic system is of clear rele-
vance to PTSD given its well documented, albeit complex role
in the regulation of emotional circuitry and fear learning (Rain-
nie, 1999; Koponen et al., 2005; Christianson et al., 2010), which
has prompted an interest in polymorphisms of the serotonin
transporter gene SLC6A4. A recent meta-analysis found that a
short allele with an SNP in the 5-HTT promoter was associated
with reduced transcriptional efficiency and increased sensitivity
to stress (Karg et al., 2011). As with Fkbp5, association of the
risk allele with PTSD occurs primarily through interactions with
environmental experiences (Kilpatrick et al., 2007; Koenen et al.,
2009; Xie et al., 2009), although some discrepancies have been
reported (Mellman et al., 2009; Koenen et al., 2011). Epigenetic
mediation of gene-environment interactions in PTSD has also
been reported for other genes related to synaptic function, such
as genes coding for Neuropeptide Y (NPY), BDNF, and mole-
cules involved in the noradrenergic and dopaminergic systems
(Boulle et al., 2012; Russo et al., 2012; Skelton et al., 2012; Wu
et al., 2013).
In contrast to Fkpb5 and SLC6A4, carriers of the 9R allele of the
dopamine transporter gene SLC6A3 were at greater risk of devel-
oping PTSD compared to 10R/10R allele carriers irrespective of
environmental factors (Chang et al., 2012), highlighting the inde-
pendent contribution of certain genes and the need to consider
environmental interactions on a gene-by-gene basis. Furthermore,
the risk for PTSD was highest in 9R allele carriers who also had
high promoter methylation (Chang et al., 2012), indicating that
epigenetic factors may mediate the contribution of genetic risk
factors, irrespective of environmental factors.
It is important to note that the studies discussed thus far have
primarily utilized a candidate-gene approach that allows for a thor-
ough assessment of polymorphisms in a single gene, but is not
suited for identifying novel genetic candidates involved in medi-
ating risk and resilience. A recent genome-wide association study
(GWAS) of trauma-exposed individuals identified a single poly-
morphism in the gene encoding the retinoic acid orphan receptor
A (RORA), to be associated with PTSD after applying stringent
genome-wide significance criteria (Logue et al., 2012). The high-
risk SNP was associated with increased risk for PTSD in response to
lower levels of trauma compared to individuals with the protective
allele. RORA is a member of the NR1 subfamily of nuclear hor-
mone receptors with neuroprotective functions (Jolly et al., 2011),
which led the authors to hypothesize that genetically mediated
differences in RORA levels are associated with an impaired stress
response (Logue et al., 2012). Studies such as this will be critical
for identifying novel candidates for PTSD risk and resilience in
distinct populations.
EPIGENETIC MEDIATION OF RISK AND RESILIENCE
Although genetic factors are essential mediators of risk and
resilience, epigenetic mechanisms also mediate the effects of severe
trauma independently of predisposing factors (Chang et al., 2012).
Indeed, the extent of epigenetic modifications observed in patients
is amplified by the severity and the number of traumatic events
experienced (Uddin et al., 2010; Koenen et al., 2011) and dis-
tinct methylation profiles of the serotonin transporter gene are
differentially associated with risk and resilience even after control-
ling for genotype (Koenen et al., 2011). Furthermore, observations
of altered DNA methylation in response to childhood abuse and
bullying (Ouellet-Morin et al., 2012) indicate that epigenetic mod-
ifications can predispose individuals to risk or resilience over and
above the variability induced by genetic factors, as found with
maternal behavior in rodents. In fact, the sensitive period for
establishing lasting effects of stress appears to extend beyond
early life into juvenile and adolescent periods of development
(McCormick and Mathews,2010; Dudley et al., 2011),as evidenced
by site-specific demethylation of fkbp5 and reduced expression of
DNMT1 in the mouse dentate gyrus of juvenile pups that were
given 4 weeks of corticosterone treatment (Yang et al., 2012).
Although individual differences in PTSD risk are well estab-
lished, relatively few studies have evaluated the specific mecha-
nisms that underlie resilience. It is not yet clear whether resilience
reflects the addition of a protective factor or the absence/reduction
of a vulnerability factor (Russo et al., 2012). Studies of gene
expression have found higher blood levels of NPY in resilient
Special Forces soldiers (Morgan et al., 2000, 2002) and higher
levels of c-Fos, FosB, and ∆FosB in resilient mice (Covington
et al., 2010; Lehmann and Herkenham, 2011; Adamec et al., 2012),
although genome-wide studies have reported altered expression in
a comparable number of genes in resilient and vulnerable popu-
lations (Benatti et al., 2012). Some evidence suggests that risk and
resilience are associated with opposite epigenetic modifications
on similar genes, wherein resilience is associated with increased
methylation and decreased expression of CRH and vulnerability is
associated with demethylation and increased expression of CRH
and fkbp5 in response to chronic stress (Elliott et al., 2010).
Epigenetic writers themselves are also candidates for mediat-
ing risk and resilience, in part through managing an appropriate
balance between epigenetic repressors and epigenetic activators
(Zovkic et al., 2013). Under baseline conditions, epigenetic repres-
sors, such as HDACs, keep gene expression in check, whereas
neuronal signaling increases gene expression in part by reliev-
ing such inhibition (Lattal et al., 2007). This repressive action of
HDACs and other molecules has been termed the molecular break
pad, reflecting the involvement of these molecules in regulating
the magnitude and the duration of gene expression (Lattal and
Wood, 2013). For example, reduction of HDAC3 expression pro-
longs the expression of immediate early genes involved in learning
and memory (McQuown and Wood, 2011; McQuown et al., 2011)
and HDAC inhibition or knockdown enhances fear learning in
rodents (Levenson et al., 2004; Guan et al., 2009; Graff and Tsai,
2011; Lesburgueres et al., 2011). An implication of these studies
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is that a disrupted balance favoring activators over repressors may
promote PTSD vulnerability by increasing the intensity of the
traumatic memory, which is consistent with reports of reduced
HDAC2 expression in the post-mortem brains of human patients
suffering from depression (Sun et al., 2013).
However, not all HDAC subtypes are memory repressors. For
example, sirtuins are class III HDACs that have been implicated in
improved cognition (Kim et al., 2007) and hippocampal overex-
pression of HDAC1 was recently associated with improved extinc-
tion of fear memory (Bahari-Javan et al., 2012). Although sirtuins
tend to be regulated by a distinct class of compounds, many phar-
macological HDACi influence a broad range of HDACs, making
it difficult to associate behavioral outcomes with specific HDAC
subtypes. For example, although chronic social defeat was found
to selectively increase the expression of the memory repressor
HDAC2, treatment with the HDACi mass spectrometry (MS)-275
had an anti-depressant effect in these rodents (Guan et al., 2009;
Covington et al., 2011b). This discrepancy may in part be associ-
ated with the relative specificity of MS-275 for HDAC1 over other
HDACs, including HDAC2 (reviewed in Grayson and Guidotti,
2013). Similarly, TSA is an HDACi that actually increases HDAC1
expression in cell culture (Ajamian et al., 2004) and given the pos-
itive role of this HDAC on fear extinction (Bahari-Javan et al.,
2012), TSA-induced enhancement of cognitive function may at
least partly be a reflection of enhanced expression of HDAC1.
In addition to HDACs, DNMTs are emerging as another class
of multifunctional epigenetic regulators with distinct modifica-
tions in PTSD, as evidenced by hypomethylation of DNMT3B
gene and hypermethylation of the DNMT3L gene (Uddin et al.,
2010). HDACs and DNMTs are only few of many epigenetic reg-
ulators involved in mediating the balance between activators and
repressors and a thorough understanding of the potential shifts in
their balance will require the consideration of these enzymes in the
context of other epigenetic mediators, including histone acetylases,
methylases, and demethylases, TET proteins, and other enzymes
that directly mediate epigenetic modifications. Complementing
these studies with genome-wide changes in gene expression will
provide valuable information regarding the effects of specific
modifications on genes associated with risk and resilience.
COGNITIVE ASPECTS OF PTSD: CAUSE AND OUTCOME
In addition to deregulation of the stress response, PTSD involves
the development of strong cognitive associations between the
stressful/fear-inducing event and the context or cue in which the
event took place. This aspect is strongly tied into PTSD symptom
expression, in that the stimuli or cues that are similar to those
associated with trauma can on their own trigger re-experiencing
of traumatic memories long after the event has passed (Ehlers
et al., 2004). Epigenetic mechanisms are particularly relevant in
this regard because of their role in the persistent stabilization of
memory for transient fear-inducing stimuli (Zovkic et al., 2013).
Existing literature on the epigenetics of fear learning has been con-
ducted primarily in the context of cognition, but the use of fear
conditioning models in PTSD makes these studies directly relevant
to the disorder. Epigenetic modifications in fear learning have been
extensively reviewed in a recent paper (Zovkic and Sweatt, 2013)
and will be discussed here only briefly to illustrate the current state
of understanding and the future directions required to advance
the application of these models to mechanistic and clinical studies
of PTSD.
A major advantage of animal models of fear learning is the
ability to assess fear expression at defined time points after the fear-
inducing stimulus to track the molecular mechanisms involved in
the establishment and perpetuation of fear memory. Assessment
of fear learning shortly after shock (2 h) best reflects the initial
response to trauma, but this is only an index of short term mem-
ory and is not well suited for assessing persistent symptoms of
PTSD, particularly given the lack of an initial emotional response
in many patients with PTSD (Friedman et al., 2011a,b). However,
this is a critical time point for evaluating epigenetic mechanisms
of fear memory consolidation that are required for stabilizing the
memory over time (Zovkic et al., 2013). Molecular assessment at
this time point may reveal different patterns or intensities of gene
expression and associated epigenetic modifications in vulnerable
and resilient individuals that can inform efforts to identify mecha-
nisms for pathological fear formation. Consolidation of cued and
contextual fear conditioning is mediated by epigenetic modifi-
cations in the amygdala, whereas epigenetic modifications in the
hippocampus are specifically involved in mediating contextual fear
learning (Levenson et al., 2004; Lubin and Sweatt, 2007; Miller
et al., 2008; Monsey et al., 2011). Consolidation of hippocampus-
dependent fear memory is typically evaluated 24 h after training,
whereas consolidation of remote memory becomes evident at least
7 days after training, when the memory from the hippocampus
has been “downloaded” to the cortex for maintenance (Frankland
et al., 2004; Ding et al., 2008). A focus on the remote time point is
especially relevant because it provides the best approximation of
the persistent and intrusive memories seen in patients with PTSD.
Given the well-defined nature of the brain regions involved in fear
consolidation and maintenance, the straight-forward behavioral
read out of fear learning (i.e., freezing), and the ease with which
stimulus (i.e., shock) intensity can be modified, this model pro-
vides an excellent platform on which to build our understanding
of epigenetic mechanisms of PTSD. For a full review of epige-
netic mechanisms of fear learning and their implications for PTSD,
please refer to a recent review from our lab (Zovkic and Sweatt,
2013).
MEMORY CONSOLIDATION
It is now well established that epigenetic mechanisms are essen-
tial mediators of fear memory consolidation. Histone acetyla-
tion, phosphorylation, and methylation play a critical role in
hippocampus- and amygdala-dependent consolidation across a
range of conditioning paradigms (Chwang et al., 2006; Leven-
son et al., 2006; Lattal et al., 2007; Lubin and Sweatt, 2007; Bredy
and Barad, 2008; Lubin et al., 2008; Miller et al., 2008; Maddox
and Schafe, 2011; Monsey et al., 2011; Stafford et al., 2012) and
interact with DNA methylation to mediate memory formation
(Miller et al., 2008; Maddox and Schafe, 2011). Pharmacologi-
cal or genetic interference with DNA methylation impairs fear
memory (Miller and Sweatt, 2007; Miller et al., 2008, 2010; Feng
et al., 2010), whereas enhancement of histone acetylation through
HDAC inhibition enhances memory formation through reduced
threshold for memory formation (Levenson et al., 2004; Bredy
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and Barad, 2008; Miller et al., 2008; Graff and Tsai, 2011; Maddox
and Schafe, 2011; Monsey et al., 2011). Similarly, knocking out
gadd45, which is involved in DNA demethylation, improves mem-
ory performance (Sultan et al., 2012), indicating that memory may
be enhanced through a paradoxical upregulation of both DNA
methylation and histone acetylation. Although a number of expla-
nations have been offered for this paradox (Zovkic et al., 2013),
recent advances implicating DNA methylation in gene activation
may also contribute to a resolution. Nevertheless, the observa-
tion of improved memory with HDACi indicates that individuals
with lower levels of HDACs and higher levels of enzymes involved
in DNA demethylation may be more sensitive to developing fear
responses that are disproportional to the traumatic event. This
proposition is particularly relevant in the context of the molecu-
lar breakpad hypothesis, in which synaptic activity overrides the
normally repressive effects of HDACs on transcription (Lattal and
Wood, 2013), in that lower levels of HDACs may allow subthresh-
old levels of synaptic activity to produce a strong memory. Thus,
an essential aim of PTSD research must be to fully characterize the
relationship between different epigenetic enzymes and PTSD, as
they relate to the consolidation of traumatic experiences. Advances
have already been made in studies of group differences under base-
line conditions in studies of human patients, which found reduced
levels of HDAC2 and altered methylation of DNMT3L genes in
PTSD (Uddin et al., 2010; Sun et al., 2013).
MEMORY MAINTENANCE
Hippocampus-dependent memory consolidation occurs within
hours of fear conditioning, when the memory begins a gradual
process of downloading to the cortex for maintenance (Fran-
kland and Bontempi, 2005). Epigenetic mechanisms have been
implicated in the initial memory transfer process in which histone
modifications in the cortex serve as a memory transfer tag (Les-
burgueres et al., 2011) and as a persistent mark for memory main-
tenance (Graff et al., 2012). In contrast to the transient changes in
DNA methylation observed in the hippocampus, fear conditioning
is associated with a persistent increase in DNA methylation and
decreased expression of the gene coding for the memory suppres-
sor calcineurin up to 30 days after fear conditioning (Miller et al.,
2010). DNA methylation is critical for memory maintenance at
this time point, such that blocking DNA methylation immediately
before a 30 day memory test impairs recall (Miller et al., 2010).
The role of DNA methylation in memory persistence is of partic-
ular relevance to PTSD given the persistent re-experiencing of the
traumatic event, indicating that manipulation of the epigenome at
appropriate time points may allow for interference with previously
established traumatic memories (see Zovkic and Sweatt, 2013 for
an expanded discussion of therapeutic implications).
MEMORY RECONSOLIDATION AND EXTINCTION
Persistent and intrusive memory recall is the foremost feature of
PTSD in humans (Orr et al., 1993). Studies of molecular events
associated with recall are critical for understanding the molecular
mechanisms that underlie the strength of the pathological mem-
ory and for identifying potential treatments. Memory recall is an
active process that renders the memory labile and employs mole-
cular mechanisms to re-stabilize the original memory (Bredy and
Barad, 2008; McKenzie and Eichenbaum, 2011; Pitman et al., 2011;
Lattal and Wood, 2013). From a treatment perspective, interfer-
ence with reconsolidation provides an opportunity to destabilize
and even erase the original traumatic memory and this avenue is
being actively pursued in patients with PTSD (Pitman, 2011). A
recalled memory also becomes subject to a second active process
termed extinction. Extinction occurs when a previously learned
association is altered by new information, such as the safety of a
conditioned stimulus in which a shock had previously occurred
(Bouton, 2004). In contrast to disrupted reconsolidation, which
effectively promotes forgetting, enhancing extinction allows for
new learning in which the fear-inducing component of the mem-
ory can be selectively disrupted while leaving the initial memory
relatively intact (Lattal and Wood, 2013). PTSD is often consid-
ered to be a disorder of extinction (Koenigs and Grafman, 2009)
and many studies with rodents have found impaired extinction in
at-risk individuals. For example, low LG and maternally separated
offspring exhibit enhanced fear conditioning and impaired extinc-
tion (Champagne et al., 2008; Bagot et al., 2009; Callaghan and
Richardson, 2011), whereas others associated brief maternal sep-
aration (15 min) with impaired fear extinction in spite of similar
rates of initial conditioning (Wilber et al., 2007, 2009; Steven-
son et al., 2009). Deficits in extinction have also been associated
with the serotonin transporter in rodents (Wellman et al., 2007;
Narayanan et al., 2011) and in people (Hartley et al., 2012), indicat-
ing that genetic risk for PTSD may be partly mediated by impaired
fear extinction.
A major challenge in applying extinction and reconsolidation
as a long-term treatment is the relative transience of extinction
relative to the original learning event and the requirement for
pharmacological intervention for robust interference with recon-
solidation (Pitman, 2011). However, recent studies in rodents
suggest that extinction may be an effective treatment strategy
when combined with manipulations of the epigenome that can
stabilize extinction learning over time (Lattal et al., 2007; Bredy
and Barad, 2008; Lattal and Wood, 2013). Specifically, administra-
tion of HDACi promotes extinction of fear learning and robust
extinction of cocaine preference that is resistant to subsequent
reinstatement by cocaine (Malvaez et al., 2010), indicating that
HDAC inhibition combined with extinction may promote adap-
tive learning that can combat deleterious adaptations. The effects
of HDACi on extinction are dependent primarily on the HDAC1
subtype (Bahari-Javan et al., 2012) and are most effective in the
infralimbic cortex (Stafford et al., 2012), which is consistent with
evidence that HATs mediate extinction specifically in this brain
region (Marek et al., 2011;Wei et al., 2012). This regional specificity
is of functional relevance because it selectively alters extinction
without impacting initial learning (Wei et al., 2012) and of trans-
lational relevance because lesions of the ventromedial prefrontal
cortex (vmPFC) impair long-term extinction in people (Quirk
et al., 2000) and reduced vmPFC activity has been reported in
patients with PTSD (Koenigs and Grafman, 2009). These studies
point to a dissociation between fear learning and fear extinction,
wherein deficits in extinction are a critical characteristic of PTSD
(Schnurr and Friedman, 2008) and may be more relevant to treat-
ment because of the temporal gap between trauma and treatment
onset. This temporal and regional difference also has implications
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for HDAC treatment, in that HDAC inhibition around the time of
trauma exposure increases fear memory, whereas HDAC inhibi-
tion in association with fear extinction enhances the extinction of
fear memory. This distinction is important to keep in mind when
developing therapies for PTSD.
Extinction, in the form of exposure therapy, is heavily uti-
lized treating PTSD (Schnurr and Friedman, 2008) and some
effort has been made toward implementing reconsolidation based
approaches in treatment (Pitman, 2011). However, more work is
needed to identify the best conditions under which behavioral
therapies are most effective when combined with pharmacologi-
cal therapies. Clinical studies suggest that contextual parameters
utilized in extinction and reconsolidation based therapies are
critical for treatment efficacy, in that similarity between treat-
ment conditions and those associated with the initial trauma
has a major impact on treatment outcomes (Pitman, 2011). In
humans and in animal models, this concept is typically investi-
gated under the umbrella of fear generalization, whereby neutral
cues can elicit fear responses based on their degree of similar-
ity to cues or contexts associated with traumatic stimuli (Dun-
smoor et al., 2009; Iordanova and Honey, 2012), but we are not
aware of studies that have directly investigated epigenetic mech-
anisms in relation to fear generalization. In humans, there is
increased use of virtual reality-based therapies to better recon-
struct traumatic scenarios (Davis et al., 2006a,b) and similar
approaches can be used to predict traumatic scenarios for sol-
diers before going into combat. Nevertheless, it is still necessary
for animal studies to combine a thorough behavioral assessment
with epigenetically based pharmacological interventions to iden-
tify the appropriate conditions for subsequent testing in human
patients.
EPIGENETICS IN DIAGNOSIS AND INTERVENTION
Epigenetic modifications may be particularly strong candidates for
use in assessing at-risk individuals for early intervention, as well
as for PTSD treatment through epigenetically based therapies. An
important first step toward such use of epigenetics involves the
establishment of “epigenetic signatures” that serve as diagnostic
markers and help identify targets for directed treatment. The idea
of an epigenetic signature is driven by the assumption that PTSD
is associated with consistent alterations in the epigenome across
individuals and that these modifications can be used as markers
of risk, resilience, and symptom severity. We have discussed much
of the substantial progress that has been made toward identifying
common epigenetic modifications in at-risk and resilient popu-
lations (see discussion of gene-environment-epigenome interac-
tions above) and systematic investigations of these modifications
can be of tremendous importance for directing early interven-
tion (Uddin et al., 2010). Indeed, studies in animal models have
exhibited encouraging results regarding the reversal of risk factors
and cognitive deficits through enrichment and epigenetic inter-
vention in juvenile and adult rodents (e.g., Francis et al., 2002;
Fischer et al., 2007), indicating that early detection of risk may
be key for PTSD prevention. Epigenetic markers will also be use-
ful in PTSD diagnosis and in tracking therapeutic efficacy after
trauma.
Although it is unlikely that any two individuals will have identi-
cal epigenetic profiles in response to trauma, it is conceivable that
a substantial amount of overlap in essential genes will be found
across patients, as evidenced by reports of altered DNMT, FKBP5,
SLC6A4, and GR methylation reviewed above. Moreover, recent
studies have demonstrated similar levels of DNA methylation of
SLC6A4 andFKBP5 genes in the blood and the brain (Suomi, 2011;
Klengel et al., 2013), indicating that the epigenetic status of cer-
tain genes in the brain may be indicated by changes in the blood.
However, differences in function between immune cells and neu-
rons must be taken into account, as early life stressors are known
to modify immune cell function (Lam et al., 2012) and immune
system alterations are commonly observed in PTSD (Smith et al.,
2011). The degree to which concordance between brain and blood
is replicable and applicable to other genes remains to be deter-
mined, but such concordance is less relevant for many clinical
purposes than the ability of peripheral markers to reliably predict
PTSD symptoms.
Nevertheless, tracking changes in pre- and post-treatment epi-
genetic profiles would be particularly useful for identifying genes
that are modified by behavioral and epigenetic interventions as
a first step in developing targeted therapies. In addition, it may
be possible to identify the changes that are associated with per-
sistent positive outcomes and to use this information to tailor
more effective therapies. Indeed, an extinction-specific role of
HDAC1 has already been identified for fear learning and a library
of such markers would provide a valuable tool for designing
epigenetic therapies to specifically enhance the efficacy of corre-
sponding behavioral therapies. The efficacy of epigenetic interven-
tion is evidenced by the fact that anti-depressant drugs produce
epigenetic modifications (Tsankova et al., 2004, 2006) and that
epigenetic drugs have anti-depressant effects (Covington et al.,
2011b).
Epigenetic therapies, including HDACi, may be particularly
strong candidates for PTSD treatment because they do not tar-
get a single neurotransmitter system and often exhibit therapeutic
or behavioral effects only under appropriate signaling conditions
(Roozendaal et al., 2010; Graff and Tsai, 2011). These phar-
macological features are relevant to many psychiatric disorders,
including PTSD, which exhibit deregulation of multiple neuro-
transmitter and signaling molecules (e.g., serotonin, NPY, GR,
Fkpb5, BDNF, and CRH) and are typically treated by drugs such
as fluoxetine that are targeted against specific neurotransmitter
systems (Steckler and Risbrough, 2012). It is now evident that
up- and down-regulation of the various deregulated molecules is
at least partly mediated by altered DNA methylation and histone
acetylation (Costa et al., 2003; Dong et al., 2007; Kinnally et al.,
2011; Koenen et al., 2011; Klengel et al., 2013), indicating that epi-
genetic drugs may stabilize function across a range of disrupted
molecules. For example, upregulation of FKBP5 in high-risk indi-
viduals is associated with reduced methylation of the GRE, which is
demethylated by exposure to glucocorticoids during early devel-
opment (Klengel et al., 2013). Similarly, reduced levels of reelin
and 67-kDA glutamate decarboxylase (GAD67) have been attrib-
uted to DNA hypermethylation in mice (Costa et al., 2003; Dong
et al., 2007).
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On the flip side, many of the molecules we are discussing
also alter gene expression through downstream effects on the
epigenome and some evidence suggests that the bidirectional
relationship across levels of regulation is a key driver or appro-
priate and stimulus-specific effects on behavior. For example,
PKA-pCREB/CBP signaling and GR receptor activation drive
changes in histone acetylation and hippocampus-dependent
learning (Levenson et al., 2004; Roozendaal et al., 2010; Mad-
dox and Schafe, 2011; Monsey et al., 2011), but HDACi could
only enhance learning in the presence of GR activation (Roozen-
daal et al., 2010), indicating that increasing histone acetylation
exerts behavioral effects only in the presence of appropriate
signaling.
In addition to driving gene expression in mental disorders,
epigenetic drugs may also normalize deregulated gene expres-
sion. For example, reduced gene expression and increased DNA
methylation in schizophrenia were reversed by treatment with
HDACi and this effect was associated with an improvement in
psychotic symptoms (Costa et al., 2003; Tremolizzo et al., 2005a;
Dong et al., 2007). Similarly, positive outcomes were reported
for the HDACi valproic acid when given in conjunction with
antipsychotics (Wassef et al., 2000, 2001; Grayson et al., 2010)
or anti-depressants (Schroeder et al., 2007). Additionally, stud-
ies in rodents reported enhanced extinction of fear (Lattal et al.,
2007; Bredy and Barad, 2008) and reduced depression (Coving-
ton et al., 2011b) in response to HDACi treatment, indicating that
these drugs may be efficacious through effects on cognitive and
affective processes. Even treatments that do not directly manipu-
late the epigenome produce epigenetic changes, with behavioral
enrichment improving cognitive deficits through similar effects
on chromatin regulation as HDACi (Fischer et al., 2007). Thus,
a combination of environmental and pharmacological treatments
may provide strongest candidates for early intervention or treat-
ment. However, it is important to caution that outcomes associated
with HDAC treatment in humans have been mixed (Narayan and
Dragunow, 2010) and may be partly attributed to administration
of adjunct therapies and the stage of the disease at the time of
treatment (Tsai review). The development of more specific drugs
and under appropriate conditions will be essential for improving
the clinical efficacy of epigenetic therapies.
A number of issues must be addressed in designing epige-
netic drugs with greater efficacy, including improved blood-brain-
barrier (BBB) permeability and increased specificity for brain
regions and HDAC subtypes (Grayson et al., 2010). HDACs are
differentially distributed throughout the brain (Broide et al., 2007)
and a growing number of studies point to distinct effects of specific
HDAC subtypes in distinct brain regions and behavioral phe-
nomena (Kim et al., 2007; Bahari-Javan et al., 2012; Sun et al.,
2013). There is already a range of drugs that have different lev-
els of regional and subtype specificity, with one study reporting
that systemic injections of the BBB-permeable MS-275 (an HDACi
selective for HDAC1 over HDAC3 and 8) selectively enhanced H3
acetylation in the frontal cortex and the hippocampus, but not
the striatum (Simonini et al., 2006). In that study, MS-275 was
more potent than valproic acid, which induced similar changes
in acetylation across brain regions (Simonini et al., 2006). With
more studies demonstrating HDAC-subtype specific effects on
neural function and behavior (Kim et al., 2007; Bahari-Javan et al.,
2012; Hanson et al., 2013), drugs that can be systemically admin-
istered and produce selective effects will be critical for targeted
treatments. Interestingly, studies of human T23 bladder and MDA
breast carcinoma, as well as HL60 cells, found a similar proportion
of genes to be up- and down-regulated in response to treatment
with HDACi (Glaser et al., 2003; Halsall et al., 2012), indicating
that the effects of HDACi are not exclusively activating. Indeed, a
high level of complexity and balance between memory activators
and repressors necessitates that some genes are turned off in order
for others to be effectively turned on (Zovkic et al., 2013).
Discussions of epigenetic treatments rightfully caution about
the potential for wide-spread and non-specific effects on
gene expression. However, microarray analysis of changes in
hippocampal gene expression in response to l-methionine treat-
ment only affected 1% of all the genes (Weaver et al., 2006), indicat-
ing that manipulations of epigenetic precursors and enzymes may
produce surprisingly specific outcomes. Similarly, treatment of
HL60 cells with three commonly used HDACi (VPA, TSA, SAHA)
altered the expression of approximately 9% of genes, with only
minor increases in histone acetylation observed at gene promoters
(Halsall et al., 2012).
Moreover, manipulations of HDACs result in at least partly dis-
criminant changes in acetylation, with HDAC1 having no effect
on AcH3K14 and AcH4K5 (Bahari-Javan et al., 2012) and MS-
275 altering AcH3K9 without affecting H4K12 (Simonini et al.,
2006; Peleg et al., 2010). In addition to gene- and residue-specific
effects, HDAC2 selectively enhances inhibitory synaptic function
in the CA1 (Hanson et al., 2013), indicating that there is poten-
tial for specificity among epigenetic therapies. Much work is
still needed to improve target specificity and the mechanisms of
HDACi actions are not always clear, given the potential for the dis-
ruption of repressive complexes and effects on non-histone targets,
which can be difficult to tease apart from effects of these drugs on
histone acetylation (Zovkic et al., 2013). Thus, the development
of increasingly specific therapies and a full characterization of the
effects of existing therapies are important for developing drugs
that can influence specific types of neural activity in selected brain
regions.
FUTURE DIRECTIONS
In the present review, we focused heavily on developmental and
genetic factors that predispose or protect individuals from PTSD.
In many of these studies, the degree to which a manipulation is
adaptive in adulthood is determined by reactivity to acute stres-
sors outside of the context of PTSD. While these studies provide
valuable insights into variable responses to trauma, a thorough
assessment of persistent symptoms over prolonged periods of time
is required to better model the lasting and intrusive nature of
PTSD in people. Fear conditioning is one example of a model
that is amenable to testing at different time points that can be
used to characterize epigenetic changes that extend beyond the
initial response to trauma and include trauma maintenance (see
Tables 1 and 2 for summary of epigenetic modifications in fear
conditioning and PTSD models). It will also be important to com-
bine developmental models with models of PTSD that sort animals
according to symptom development, severity, and persistence. This
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Table 1 | A summary of epigenetic modifications reported in rodent models of fear conditioning.
Epigenetic modification measured Gene Brain region Effect Reference
MEMORY CONSOLIDATION (30 min–2 h AFTER FEAR CONDITIONING)
Global CA1 ↑ Chwang et al. (2006), Levenson et al. (2004), Miller et al. (2008)
Bdnf IV promoter
CA1 ↑ Lubin et al. (2008)
H3 acetylation Hippocampus ↑ Takei et al. (2011)
Homer 1 promoter Hippocampus ↑ Mahan et al. (2012)
Global Lateral amygdala ↑ Monsey et al. (2011), Maddox et al. (2013)
H3 phosphorylation Global CA1 ↑ Chwang et al. (2006)
H3 phosphoacetylation Global CA1 ↑ Chwang et al. (2006)
H3K9me2 Global Entorhinal cortex ↑ Gupta-Agarwal et al. (2012)
H3K4me3
Global CA1 ↑ Gupta et al. (2010), Gupta-Agarwal et al. (2012)
zif268 promoter CA1 ↑ Gupta et al. (2010)
BDNF I CA1 ↑ Gupta et al. (2010)




↑ Miller and Sweatt (2007)
Reelin ↓ Miller and Sweatt (2007)
Bdnf ↓ Lubin et al. (2008)
zif268 ↑ Gupta et al. (2010)
MEMORY MAINTENANCE (7–30 DAYS)
DNA methylation Calcineurin PFC ↑ Miller et al. (2010)
will be especially useful in distinguishing between early life expe-
riences acting as stress inoculators vs. risk inducers in relation to
adult risk and resilience. Ideally, early life manipulations will be
combined with genetic models to reflect the gene-environment
interactions identified in human risk populations. It is important
to note that the rapid pace at which novel techniques are devel-
oped poses an opportunity and a challenge for conducting cutting
edge research that can shed new light on our understanding of
PTSD and psychiatric disorders. Most rapid advancements are
particularly evident for techniques differentiating between DNA
methylation and hydroxymethylation. Given the role of 5hmC in
DNA demethylation and the distinct association of each modifi-
cation with gene regulation, we have included a summary of new
approaches to facilitate their application in studies of PTSD (see
Box 1).
In addition to affecting gene expression through the direct
interaction with transcriptional machinery, DNA methylation is
increasingly being recognized as an incredibly complex regulator
of neuronal function and metaplasticity (Baker-Andresen et al.,
2013). For example, de novo DNA methylation was shown to pre-
vent RNA polymerase stalling, thus providing a mechanism by
which DNA methylation can regulate alternative splicing (Shukla
et al., 2011). The long-term regulation of alternative splicing
by DNA methylation may affect the responsivity of neurons to
future stimuli (Baker-Andresen et al., 2013); thus investigations
into the epigenetic regulation of alternative splicing are warranted
in delineating factors that convey resilience to PTSD. Addition-
ally, DNA methylation has been implicated in the regulation of
retrotransposons, such as the positioning of long interspersed
nuclear elements-1 (LINE-1) (Muotri et al., 2010). This is impor-
tant, as the insertion of LINE-1 into various genomic regions may
increase gene length, which is associated with decreased efficiency
of expression (Castillo-Davis et al., 2002). Interestingly, a recent
report demonstrated that a post-deployment diagnosis of PTSD
was associated with hypomethylation of LINE-1, suggesting that
methylation of these elements may play a role in mediated risk
or resilience (Rusiecki et al., 2012). The existence of 5hmc and of
distinct cofactors that interact with 5mc and 5hmc (Spruijt et al.,
2013) further complicates the interpretation and calls for the use
of techniques that distinguish between these modifications (see
Box 1). Such approaches will be critical for identifying epigenetic
signatures that differentiate between risk and resilience.
Finally, although women are more likely to develop PTSD
than men, mot rodent studies have been conducted only in males
(Mulchahey et al., 2001; Pope et al., 2003). Thus, a greater focus
on females is warranted and may help us understand the basis for
relative resilience in men, with testosterone providing one possible
candidate for resilience (Russo et al., 2012). Some existing evidence
suggests that sex differences are will be relevant for understanding
all aspects of PTSD, with prenatal stress producing altered levels
of DNMT1 expression, hippocampal GR methylation, and hypo-
thalamic CRH methylation in adult male, but not female, offspring
(Mueller and Bale, 2008). In addition, evidence from rodent stud-
ies suggests that sex differences vary for distinct components of
PTSD, with females exhibiting vulnerability in tests of motivation
and affect, while exhibiting resilience in non-stressful cognitive
tasks (Luine, 2002).
CONCLUSION
In this review, we have demonstrated that epigenetic mechanisms
are fundamental regulators of predisposition and resilience to
PTSD, primarily through mediating gene-environment interac-
tions during sensitive periods of development. Epigenetic mech-
anisms are also essential mediators of proximal causes of PTSD
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Table 2 | A summary of epigenetic modifications in human and animal models of PTSD.
Species/model Gene(s) of interest Major findings Reference
CANDIDATE-GENE STUDIES




Bdnf ↑ Exon IV methylation in dorsal DG and CA1, ↓ exon IV methylation in
ventral CA3, ↓ exon IV mRNA in both dorsal and ventral CA1
Roth et al. (2011)
Human SLC6A4 Controlling for genotype, SLC6A4 methylation modified the effect of
PTEs on PTSD: ↓ SLC6A4 promoter methylation associated with ↑ PTSD
risk; ↑ SLC6A4 promoter methylation was protective against PTSD
Koenen et al. (2011)
Human SLC6A3 ↑ SLC6A3 promoter methylation associated with ↑ risk of lifetime PTSD
in 9R allele carriers
Chang et al. (2012)
Human COMT COMT Met/Met genotype interacted with CpG methylation in
mediating impaired fear inhibition in PTSD patients
Norrholm et al.
(2013)
Human FKBP5 GC exposure was associated with ↑ FKBP5 GRE demethylation and ↑
FKBP5 expression in carriers of the risk compared with the protective
allele
Klengel et al. (2013)
GENOME-WIDE/LARGE SCALE STUDIES





PTSD was associated with: (1) ↑ methylation of DNMT3B, ↓methylation
of DNMT3L; (2) degulated methylation of genes involved in Prader–Willi
and Angelman syndromes; (3) methylation profiles suggesting
upregulation of immune-related genes and downregulation of genes
involved in neurogenesis and the startle response
Uddin et al. (2010)
Rat – predator odor Dlgap2, Dll3, Pkcη, Rps6kb2 Of the four differentially methylated genes identified, Dlgap2 was
associated with a change in mRNA expression. ↓ intragenic methylation
associated with ↓ hippocampal mRNA expression
Chertkow-Deutsher
et al. (2010)
Human TPR, CLEC9A, APC5, ANXA2,
TLR8, BDNF, CXCL1,
immune-related genes
PTSD associated with: (1) ↓ methylation ofTPR and ANXA2 and ↑
methylation of CLEC9A, APC5,TLR8 in PTSD; (2) ↑ methylation of
BDNF and CXCL1; (3) 19 of 54 of the differentially methylated
immune-related genes examined in Uddin et al. (2010)
Smith et al. (2011)
OTHER
Human 33 loci previously associated
with PTSD
Only MAN2C1 showed evidence of interaction with PTE no. in PTSD
risk: ↑MAN2C1 methylation interacted with ↑ no. of PTEs to ↑ PTSD risk
Uddin et al. (2011)
Human Repetitive elements: LINE-1,
Alu
In US military service members recently deployed to Afghanistan or Iraq:
LINE-1 was hypomethylated in PTSD cases vs. control post-deployment.
Alu was hypermethylated in PTSD cases vs. control pre-deployment
Rusiecki et al. (2012)
PTE, potentially traumatic event; TLS, total life stress; ADCYAP1, adenylate cyclase-activating polypeptide 1 (pituitary); ADCYAP1R1, adenylate cyclase-activating
polypeptide 1 (pituitary) receptor type I; Bdnf, brain-derived neurotrophic factor; SLC6A4, solute carrier family 6 (neurotransmitter transporter, serotonin), member;
SLC6A3, solute carrier family 6 (neurotransmitter transporter, dopamine), member; COMT, catechol-O-methyltransferase; FKBP5, FK506 binding protein 5; DNMT3B,
DNAmethyltransferase-3B; DNMT3L, DNAmethyltransferase-3L; NDN, necdin, melanoma antigen (MAGE) family member; MAGEL2, MAGE-like 2; ATP10A, ATPase,
class V, type 10A; Dlgap2, disks large-associated protein 2; Dll3, delta-like 3; Pkcη, protein kinase C η; Rps6kb2, ribosomal protein S6 kinase polypeptide 2; TPR,
translocated promoter region; CLEC9A, C-type lectin domain family 9, member A; APC5, acid phosphatase 5, tartrate resistant; ANXA2, annexin A2; TLR8, toll-like
receptor 8; CXCL1, chemokine (C-X-C motif) ligand 1; MAN2C1, mannosidase, alpha, class 2c, member 1.
because of their role in stabilizing persistent outcomes of transient
traumatic events. Although much progress has been made toward
identifying epigenetic contributions to PTSD, ongoing shifts in
our fundamental understanding of epigenetic modifications and
their function call for the use of new technologies to clarify the
role of these modifications in psychiatric disorders. As our appre-
ciation of the complex roles of epigenetic mechanisms increases,
so will our ability to create new and effective interventions for this
incredibly complex and devastating human disease.
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